Amisulpride has a superior benefit/risk profile to haloperidol in schizophrenia: results of a multicentre, double-blind study: (the Amisulpride Study Group)

• 作者P Carrière; D Bonhomme; T Lempérière
• 卷第15卷
• 期第5期
• 文件大小119.89KB
• 发表时间2000
• DOI10.1016/s0924-9338(00)00401-6
• 页码321-329